niacinamide has been researched along with Brain Diseases in 11 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " With expanded clinical experience with this class of agents has come the increasing recognition of the diverse adverse effects related to disturbance of VEGF-dependent physiological functions and homeostasis in the cardiovascular and renal systems, as well as wound healing and tissue repair." | 2.45 | Adverse effects of anticancer agents that target the VEGF pathway. ( Chen, HX; Cleck, JN, 2009) |
| "Cytoflavin therapy at a dosage of 2 tablets 2 times a day for 25 days can be recommended as part of complex therapy for patients with DE and a COVID-19." | 1.91 | [Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection]. ( Belova, LA; Dolgova, DR; Kruglova, LR; Kuvayskaya, AA; Mashin, VV; Plaksina, TD; Sukhikh, SS, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Belova, LA | 1 |
| Mashin, VV | 1 |
| Dolgova, DR | 1 |
| Kuvayskaya, AA | 1 |
| Kruglova, LR | 1 |
| Sukhikh, SS | 1 |
| Plaksina, TD | 1 |
| Tsygan, IV | 1 |
| Chen, HX | 1 |
| Cleck, JN | 1 |
| Kuchmerovska, T | 1 |
| Shymanskyy, I | 1 |
| Chlopicki, S | 1 |
| Klimenko, A | 1 |
| LeWitt, PA | 1 |
| Brooks-Hill, RW | 1 |
| Bishop, ME | 1 |
| Vellend, H | 1 |
| Balaban, CD | 1 |
| Tabaqchali, S | 1 |
| Pallis, C | 1 |
| Swash, M | 1 |
| Roberts, AH | 1 |
| Murnaghan, DJ | 1 |
| Herken, H | 2 |
| Lange, K | 1 |
| Kolbe, H | 1 |
1 review available for niacinamide and Brain Diseases
| Article | Year |
|---|---|
Adverse effects of anticancer agents that target the VEGF pathway.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2009 |
10 other studies available for niacinamide and Brain Diseases
| Article | Year |
|---|---|
[Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection].
Topics: Aged; Brain Diseases; COVID-19; Female; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide | 2023 |
[Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
Topics: Aged; Brain Diseases; Cardiopulmonary Bypass; Cognitive Dissonance; Drug Combinations; Female; Flavi | 2013 |
1-methylnicotinamide (MNA) in prevention of diabetes-associated brain disorders.
Topics: Animals; Brain Diseases; Diabetes Mellitus, Experimental; Male; Niacinamide; Rats; Serotonin; Signal | 2010 |
The neurotoxicity of the rat poison vacor. A clinical study of 12 cases.
Topics: Adult; Brain Diseases; Diabetes Mellitus; Humans; Hypotension, Orthostatic; Male; Middle Aged; Nervo | 1980 |
Pellagra-like encephalopathy complicating a multiple drug regimen for the treatment of pulmonary infection due to Mycobacterium avium-intracellulare.
Topics: Antitubercular Agents; Brain Diseases; Drug Therapy, Combination; Female; Humans; Lung Diseases; Mid | 1985 |
Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: a critical review of central 3-acetylpyridine neurotoxicity.
Topics: Animals; Brain Diseases; Corpus Striatum; Harmaline; Hippocampus; Limbic System; Male; Medulla Oblon | 1985 |
Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis.
Topics: Acute Disease; Aged; Brain Diseases; Diverticulum; Female; Humans; Injections, Intravenous; Jejunum; | 1970 |
Reversible pellagra-like encephalopathy with ethionamide and cycloserine.
Topics: Brain Diseases; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Niacinamide; | 1972 |
Functional disorders of the brain induced by synthesis of nucleotides containing 3-acetylpyridine.
Topics: Adenine Nucleotides; Animals; Brain; Brain Diseases; Cerebral Cortex; Folic Acid Antagonists; Glucos | 1968 |
Brain disorders induced by pharmacological blockade of the pentose phosphate pathway.
Topics: Animals; Brain; Brain Diseases; Carbon Isotopes; Cell Nucleus; Endoplasmic Reticulum; Glucose; Gluco | 1969 |